Antipsychotic long-acting injections

Antipsychotic long-acting injections

by Peter Haddad, Tim Lambert, John Lauriello
     
 

Antipsychotic long-acting injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Recently there has been a resurgence of interest in LAIs that partly reflects the introduction of several second-generation antipsychotic LAIs. This book

See more details below

Overview

Antipsychotic long-acting injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Recently there has been a resurgence of interest in LAIs that partly reflects the introduction of several second-generation antipsychotic LAIs. This book brings together clinical and research findings on LAIs in a comprehensive volume, with chapters being written by international experts. Though the book concentrates on the use of LAIs in schizophrenia, the emerging evidence base for the use of LAIs in bipolar disorder is also discussed. A repeated theme throughout the book is the importance of prescribing decisions - whether for oral medication or an LAI, reflecting a shared decision making process by the prescriber and patient. The authors stress that antipsychotic LAIs are not suitable for all patients and are only one possible solution to adherence problems. Providing a synthesis and broad picture of the place of LAIs in current clinical practice, and looking at both their advantages and disadvantages, this book will be valuable for psychiatrists, psychopharmacologists, and pharmacists.

Read More

Editorial Reviews

Doody's Review Service
Reviewer: Aaron Plattner, MD (Pine Rest Christian Mental Health Services)
Description: This book examines where long-acting antipsychotic injections fit into the treatment of various psychiatric patients by providing up-to-date data on both older and newer long-acting antipsychotic injections compared to oral medications.
Purpose: With the recent introduction of several second-generation, long-acting antipsychotic medications as well as other factors, there has been an increased interest in and important research on long-acting antipsychotic medications. This book is the first to properly educate mental health providers on this new information.
Audience: The editors identify the intended audience as psychiatrists, psychiatric nurses, psychopharmacologists, and pharmacists, who would all benefit from this book. In addition, nurse practitioners and physician assistants, particularly those in the area of community psychiatry, would find this book helpful.
Features: Most of the clinical use, and thus research, of long-acting antipsychotic medication is focused on schizophrenia, which is reflected in large sections of this book, but the book also reviews the clinical and research findings of long-acting antipsychotics in the treatment of bipolar disorder and early psychosis. Also addressed are the issues of adherence and attitudes of patients and providers to long-acting antipsychotic medications compared to oral antipsychotic medications. Throughout, the book reviews the benefits, adverse effects, and risks of first- and second-generation oral antipsychotic medications compared to first- and second- generation long-acting injections. Helpful tables, graphs, references, and an index are also present.
Assessment: This book accomplishes the difficult task of condensing a great deal of clinical experience and research data into one complete, unbiased book. It does so through the contributions of a variety of internationally known psychiatrists, which also leads to some redundancy and discussions of medications that may not be available to providers in the United States. In an effort to present the large amount of new data, some sections can be extremely dense and would benefit from using more charts and/or graphs to convey the information. Perhaps this will be accomplished in a later version, which will be needed as more second-generation, long-acting antipsychotic medications are produced. Still, this is a well-written book, particularly the sections on the newer second-generation, long-acting antipsychotic medications and the utility of long-acting antipsychotic injections for bipolar disorder and early psychosis. The editors should be praised for addressing the importance of the attitudes and convictions of patients and providers regarding oral versus long-acting injection medications.

Read More

Product Details

ISBN-13:
9780199586042
Publisher:
Oxford University Press
Publication date:
12/09/2010
Pages:
282
Product dimensions:
6.10(w) x 9.10(h) x 0.60(d)

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >